Immunohistochemistry (IHC) Market: Size, Share, Forecasts, and Trends
Comprehensive Analysis of Immunohistochemistry Market Trends and Forecast
Meticulous Research®, a prominent global market
research firm, has released an in-depth report titled "Immunohistochemistry
(IHC) Market Size, Share, Forecast, & Trends Analysis by Offering
(Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining,
Imaging] Method (ABC, CSA, PAP) Process, Application, End User—Global Forecast
to 2031."
According to Meticulous Research®, the global
immunohistochemistry market is poised to achieve a valuation of $4.08 billion
by 2031, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to
2031. This growth trajectory is driven by several factors, including the
rising incidence of chronic diseases and an expanding elderly population, an
increased focus on rare diseases, heightened awareness regarding early disease
detection, augmented research and development investments, a surge in drug
discovery and development efforts, growing prevalence of infectious diseases,
and escalating healthcare expenditures.
Additional growth opportunities are expected from the shift
towards personalized medicine, advancements in genomics and proteomics, and the
increasing automation of immunohistochemistry processes. However, challenges
such as stringent technical requirements, complex regulatory procedures, and
the availability of alternative technologies could impede market expansion.
Key Market Players
Prominent companies in the global immunohistochemistry
market include F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation
(U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad
Laboratories, Inc. (U.S.), Eagle Biosciences, Inc. (U.S.), Thermo Fisher
Scientific Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), PerkinElmer,
Inc. (U.S.), Bio SB Inc. (U.S.), Biocare Medical, LLC (U.S.), Bio-Genex
Laboratories (U.S.), CANDOR Bioscience GmbH (Germany), and Innovex Biosciences
Inc. (U.S.).
Market Segmentation and Insights
The immunohistochemistry market is segmented based on
Offering (Consumables [Reagents {Fixation Reagents, Antigen Retrieval, Buffers,
Blocking Reagents, Antibodies, Control Reagents, Chromogenic Substrates, and
Counterstain}, and Other Accessories], Equipment [Staining Systems, Imaging
Systems, Slide Scanners, and Tissue Microarrays], and Services & Software),
Method (Avidin-Biotin Complex, Polymer-Based Immunohistochemistry, Catalyzed
Signal Amplification [CSA], Fluorescyl-tyramide Amplification, Improved Catalyzed
Signal Amplification [iCSA], Multi-Staining Immunohistochemistry, Labeled
Streptavidin Biotin [LSAB], and PAP Method), Process (Sample Preparation,
Antigen Retrieval, Background Blocking, Target Detection, and Sample
Visualization), Application (Research Applications [Drug Discovery, Agriculture
& Animal Research, and Other Applications], and Clinical Applications
[Reproductive Health, Oncology, Infectious Disease, and Other Clinical
Applications]), End User (Pharmaceutical & Biotechnology Companies,
Hospitals & Diagnostic Laboratories, Academic Institutes & Research
Centers, and Other End Users), and Geography. The report evaluates the market
at both global and regional levels and profiles key industry competitors.
In 2024, the consumables segment is anticipated to dominate
the market, driven by advancements in IHC consumables, the benefits of IHC kits
and reagents such as reduced time between sample analysis and results, improved
access to advanced IHC solutions, and frequent use of consumables.
Among the methods studied, the avidin-biotin complex method
is projected to hold the largest market share in 2024 due to its high affinity
for biotin, resistance to enzymatic reactions, and pH stability.
In terms of applications, clinical applications are expected
to capture the largest market share in 2024, with sub-segments including
reproductive health, oncology, and infectious disease. This dominance is
attributed to the rising prevalence of chronic diseases, growing awareness of
early disease diagnosis, and increased affordability of advanced IHC solutions
in hospitals and diagnostic laboratories.
The hospitals and diagnostic laboratories segment is
forecasted to be the largest end-user segment in 2024, supported by the
expansion of healthcare facilities, the availability of well-equipped systems,
and a skilled workforce.
Geographic Outlook
The report provides a detailed geographic analysis, covering
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain,
and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea,
and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin
America), and the Middle East & Africa.
Among these regions, Asia-Pacific is expected to experience
the highest CAGR during the forecast period, driven by rapid urbanization, the
growing burden of infectious diseases, and increased investments to improve
healthcare infrastructure.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5967
Key questions answered in the report:
- Which
are the high-growth market segments in terms of offerings, method,
application, end user, and region/country?
- What
was the historical market size for immunohistochemistry globally?
- What
are the market forecasts and estimates for the period 2024–2031?
- What
are the major drivers, restraints, challenges, opportunities, and trends
in the immunohistochemistry market?
- Who
are the major players in the global immunohistochemistry market?
- What
is the competitive landscape like, and who are the market leaders in the
global immunohistochemistry market?
- What
are the recent developments in the global immunohistochemistry market?
- What
are the different strategies adopted by the major players in the global
immunohistochemistry market?
- What
are the geographical trends and high-growth regions/countries?
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment